Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. - McKinney, C; Broen, J C A; Vonk, M C; Beretta, L; Hesselstrand, R; Hunzelmann, N; Riemekasten, G; Scorza, R; Simeon, C P; Fonollosa, V; Carreira, P E; Ortego-Centeno, N; et al. (Genes & Immunity, 2012)